Genmab A/S announced that multiple abstracts evaluating epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously, will be presented at the 2023 American Society of Clinical Oncology Annual Meeting, being held in Chicago, IL and virtually, June 2-6, 2023, and at the 2023 European Hematology Association Congress, being held in Frankfurt, Germany and virtually, June 8-11, 2023.
May 25, 2023
· 15 min read